Health Wealth Fund One Series 2 LLC Amends Exempt Offering Notice

TL;DR

**Health Wealth Fund One Series 2 LLC just amended its exempt offering filing, signaling updated capital raise details.**

AI Summary

Health Wealth Fund One Series 2 LLC filed an amended Form D/A on March 24, 2026, updating its Notice of Exempt Offering of Securities. This filing, with an accession number of 0002086779-26-000005, indicates a change or correction to a previous exempt offering. For investors, this matters because it provides updated information on how the company is raising capital outside of traditional public offerings, which can impact future dilution or funding stability.

Why It Matters

This amendment provides updated details on how Health Wealth Fund One Series 2 LLC is raising capital, which can affect the company's financial structure and future growth prospects.

Risk Assessment

Risk Level: medium — Amended exempt offerings can sometimes indicate changes in funding strategy or terms, which introduces a moderate level of uncertainty for investors.

Analyst Insight

Investors should review the full D/A document if available to understand the specific changes made to the exempt offering, as these could impact the company's funding structure and potential future dilution.

Key Numbers

• 2026-03-24 — Filing Date (The date the D/A form was filed and accepted by the SEC.)
• 0002086779-26-000005 — SEC Accession No. (The unique identifier for this specific filing.)
• 14:31:09 — Accepted Time (The exact time the filing was accepted by the SEC on March 24, 2026.)
• 6208 — Complete submission text file size (The size in bytes of the full text file of the submission.)

Key Players & Entities

• Health Wealth Fund One Series 2 LLC (company) — the filer of the D/A form
• 0002086779 (company) — the CIK (Central Index Key) for the filer
• 393345482 (company) — the EIN (Employer Identification Number) for the filer
• DE (company) — the State of Incorporation for the filer
• 021-558499 (company) — the File Number for the offering

Forward-Looking Statements

• The amendment likely reflects updated terms or participants in the exempt offering. (Health Wealth Fund One Series 2 LLC) — medium confidence, target: 2026-06-24

FAQ

Key Financial Figures

• $1 — enues   No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,
• $1,000,000 — No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,
• $5,000,000 — Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001
• $1,000,001 — e   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000
• $5,000,001 — $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000
• $25,000,000 — $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000   $25,000,001
• $25,000,001 — $25,000,000 $5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,0
• $50,000,000 — 5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,0
• $100,000,000 — 25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $1
• $50,000,001 — 0,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $100,000,000   O

Filing Documents

• primary_doc.html (D/A)
• primary_doc.xml (D/A) — 5KB
• 0002086779-26-000005.txt ( ) — 6KB

From the Filing

Form D FORM D Notice of Exempt Offering of Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. OMB APPROVAL OMB Number: 3235-0076 Estimated Average burden hours per response: 4.0 1. Issuer's Identity CIK (Filer ID Number) Previous Name(s) None Entity Type Health Wealth Fund Series 2 LLC Corporation Limited Partnership   Limited Liability Company   General Partnership   Business Trust Other   Name of Issuer   Health Wealth Fund One Series 2 LLC Jurisdiction of Incorporation/Organization DELAWARE   Year of Incorporation/Organization Over Five Years Ago Within Last Five Years (Specify Year) 2025 Yet to Be Formed           2. Principal Place of Business and Contact Information Name of Issuer   Health Wealth Fund One Series 2 LLC Street Address 1 Street Address 2   3472 RESEARCH PKWY STE 104   PMB171   COLORADO SPRINGS   COLORADO     80920   412-337-5254   3. Related Persons Last Name First Name Middle Name Peak Andrew John Street Address 1 Street Address 2   3472 Research Pkwy Ste 104     PMB171   Colorado Springs   COLORADO   80920   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary)   4. Industry Group   Agriculture Banking & Financial Services     Commercial Banking     Insurance   Investing     Investment Banking     Pooled Investment Fund   Other Banking & Financial Services   Business Services Energy     Coal Mining     Electric Utilities     Energy Conservation     Environmental Services     Oil & Gas     Other Energy Health Care     Biotechnology     Health Insurance     Hospitals & Physicians     Pharmaceuticals     Other Health Care                         Manufacturing Real Estate   Commercial   Construction   REITS & Finance   Residential Other Real Estate   Retailing Restaurants Technology   Computers   Telecommunications   Other Technology Travel   Airlines & Airports   Lodging & Conventions   Tourism & Travel Services   Other Travel Other        5. Issuer Size Revenue Range Aggregate Net Asset Value Range No Revenues   No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $100,000,000   Over $100,000,000   Decline to Disclose   Decline to Disclose   Not Applicable   Not Applicable   6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply) Rule 504(b)(1) (not (i), (ii) or (iii)) Rule 506(b)         Rule 504 (b)(1)(i) Rule 506(c) Rule 504 (b)(1)(ii) Securities Act Section 4(a)(5) Rule 504 (b)(1)(iii) Investment Company Act Section 3(c)     7. Type of Filing   New Notice Date of First Sale   2025-08-07   First Sale Yet to Occur   Amendment     8. Duration of Offering Does the Issuer intend this offering to last more than one year?   Yes   No     9. Type(s) of Securities Offered (select all that apply) Pooled Investment Fund Interests Equity Tenant-in-Common Securities Debt Mineral Property Securities Option, Warrant or Other Right to Acquire Another Security Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security Other (describe)       10. Business Combination Transaction Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?   Yes   No Clarification of Response (if Necessary)       11. Minimum Investment Minimum investment accepted from any outside investor $   200000 USD 12. Sales Compensation Recipient   Recipient CRD Number None     (Associated) Broker or Dealer None (Associated) Broker or Dealer CRD Number  None     Street Address 1 Street Address 2             13. Offering and Sales Amounts   Total Offering Amount $ 20000000 USD Indefinite Total Amount Sold $ 19873260 USD Total Remaining to be Sold $ 126740 USD Indefinite Clarification of Response (if Necessary)      14. Investors Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, Number of such non-accredited investors who already have invested in the offering       Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 84   15. Sales Commissions & Finders’ Fees Expenses Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount. Sales Commissions $ 0 USD Estimate Finders' Fees $ 0 USD Estimate Clarification of Response (if Necessary)     16. Use of Proceeds Provide the amount of the gross proceeds of

View Full Filing

View this D/A filing on SEC EDGAR